Hyperhidrosis (or excessive sweating) and bothersome sweating can be reduced with Botox.  Botox is an FDA-approved, proven treatment to reduce non-pathologic (primary) hyperhidrosis of the underarms.  

Affecting 1-5% of people, hyperhidrosis is a common condition characterized by heavier-than-normal sweating that is unrelated to heat or exercise, and often occurs on the face, axillas, palms and soles. 

Hyperhidrosis or bothersome sweating can cause anxiety or embarrassment at work and in in social settings, as well as frustration due to having one's clothes ruined by sweat stains.

‍

There are two types of hyperhidrosis: 

• Primary (focal) hyperhidrosis (of unknown cause) and 
• Secondary (generalized) hyperhidrosis (caused by a disease or medication side effect)

Primary hyperhidrosis has no known cause, but is sometimes inherited.  Generally, onset is in childhood or adolescence or before the age of 25 and is usually focal, affecting the face, axillas, palms and / or soles. Also, primary focal hyperhidrosis is usually bilateral and symmetrical, affecting both axillas, palms and / or soles and episodes occur at least weekly.

Botox is useful for reducing sweating in the locations of primary hyperhidrosis.

Alternative and/or ancillary treatment options for hyperhidrosis include topically applied over-the-counter and/or prescription antiperspirants, including:

• Drysol, Qbrexa (topical glycopyrrolate)
• Iontophoresis (for hands and feet) 
• miraDry for axillary hyperhidrosis (microwave technology)
• Oral medications [anticholinergics, including glycopyrrolate (Robinol) and others]
• Endoscopic thoracic sympathectomy (a last resort for palmar/hand sweating)